skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Humans remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Salem, M.E. ; Yin, J. ; Goldberg, R.M. ; Pederson, L.D. ; Wolmark, N. ; Alberts, S.R. ; Taieb, J. ; Marshall, J.L. ; Lonardi, S. ; Yoshino, T. ; Kerr, R.S. ; Yothers, G. ; Grothey, A. ; Andre, T. ; De Gramont, A. ; Shi, Q.

Annals of oncology, 2020-04, Vol.31 (4), p.480-486 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

de Vos, S. ; Swinnen, L.J. ; Wang, D. ; Reid, E. ; Fowler, N. ; Cordero, J. ; Dunbar, M. ; Enschede, S.H. ; Nolan, C. ; Petrich, A.M. ; Ross, J.A. ; Salem, A.H. ; Verdugo, M. ; Agarwal, S. ; Zhou, L. ; Kozloff, M. ; Nastoupil, L.J. ; Flowers, C.R.

Annals of oncology, 2018-09, Vol.29 (9), p.1932-1938 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

Sabatier, R. ; Eymard, J.C. ; Walz, J. ; Deville, J.L. ; Narbonne, H. ; Boher, J.M. ; Salem, N. ; Marcy, M. ; Brunelle, S. ; Viens, P. ; Bladou, F. ; Gravis, G.

Annals of oncology, 2012-03, Vol.23 (3), p.714-721 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

Rohatiner, A.

Annals of oncology, 1994-05, Vol.5 (5), p.397-400 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.